Nature

Validation of a neurological-exam-based rating scale (FARS) for Friedreich's ataxia

To evaluate whether the Friedreich Ataxia Rating Scale (FARS; rates the severity of FA on the basis of a neurological examination) and performance-based scales are sensitive to disease burden in ...
Nature

An approach to the patient with late-onset cerebellar ataxia

Background An 83-year-old man presented with hypertension, hyperlipidemia, and a previous basal cell carcinoma, having developed progressive worsening of his balance and difficulty walking at the age ...
Hosted on MSN

PTC’s vatiquinone approval hopes dashed in Friedreich’s Ataxia

The US Food and Drug Administration (FDA) has rejected PTC Therapeutics’ new drug application (NDA) for vatiquinone in Friedreich's Ataxia. This follows the biotech’s decision to submit the ...
Medscape

Fragile X-Associated Tremor/Ataxia Syndrome–An Older Face of the Fragile X Gene

Background: A 76-year-old man presented with an 8-year history of balance problems and a 2-year history of short-term memory loss. He had also been experiencing long-term problems with impotence and ...
CBC.ca

Montreal researchers join international study of rare disease Friedreich's ataxia

Montreal researchers are joining an international study to learn more about a little-understood genetic disease that is found in Canada, and especially in Quebec and in Acadian regions of the ...